Indian CRO | Clinical Research India | Clinical Trials in India | CROs in India | Full Service CRO in India | Clinical Trials India
Indian CRO, Clinical Research India
 
Industry News
DCGI to implement e-Gov in its working The Drugs Controller General of India (DCGI) to have a single window facility for drug approval soon...
New Indian Regulatory Guidance by Central Drugs Standard Control Organization Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy - Central Drugs Standard Control Organization...
Indian Clinical Data Management market is expected to ramp up to $150 million MNCs are more than willing to outsource their needs to India because of it\'s technological innovation, creditable quality, operational flexibility, cost effectiveness, time-to-market and competitive advantage according to Koteshwar Govind, Deputy Manager,...
India: Attractive Market for Biopharmaceutical Companies Looking to Accelerate Their Clinical Trials The Clinical Research Market in India is growing at a very rapid rate according to anyone’s statistics…It is exploding according to all the hype. ...
Full Service CRO in India, Clinical Trials India
Indian CRO
Max Neeman – A leading Contract Research Organization (CRO) based out of India provides full range of clinical research services to global pharmaceutical, biotech and devices companies.

  • Based out of 6 regional offices, Max Neeman has access to hospitals and health care facilities across India.
  • Operational since 2001, Max Neeman has been awarded 185 trials for global sponsors across wide range of therapeutic areas.
  • Max Neeman has been awarded ISO 9001:2008 certification by United Kingdom Accreditation Service (UKAS) for Site Management, Monitoring and Data Management.
  • We are presently active in 175 sites in 31 cities with access to 900 ICH-GCP trained Investigators.
  • Record of maintaining a patient retention rate between 98.1 to 98.4% across different therapeutic areas.
  • Successfully completed 4 US FDA GCP Audits for highest enrollment globally.
Indian CRO, Clinical Research India
CROs in India, Full Service CRO in India
Clinical Trials in India, CROs in India
Max Neeman News
Max Neeman International Continues to Expand in Response to Increased Client Demand for Medical Writing Services Max Neeman International, India\'s premier CRO, has expanded its team of medical writers in response to the growing demand for medical writing services. The team consists of highly qualified medical writers with scientific or medical educations and clinic...
Max Neeman International Expands Data Management Services with Conversion Into CDISC Standard Data Model Max Neeman International, India\'s premier CRO, created a niche in Data Management services and has extended the platform to provide expert CDISC (Clinical Data Interchange Standards Consortium) services and modified solutions which include on-going and le...
Max Neeman International Sets Up an Exclusive Team for Cosmetic Studies Expanding Upon Dermatology Experience RESEARCH TRIANGLE PARK, N.C., June 14 /PRNewswire/ -- Max Neeman International, India\'s premier CRO, has entered into the cosmetics arena as this industry recognizes the Indian market potential due to favorable changes in the country\'s demographics. A ...
Max Neeman Announces Expansion of Central Lab Services in Partnership with Max Healthcare RESEARCH TRIANGLE PARK, N.C., May 25 /PRNewswire/ -- Max Neeman International, a full service Contract Research Organization announces set-up of company central lab services beginning with a Phase II study in Oncology. The India-based CRO will be respons...
Max Neeman International Signs Agreement for Data Management/EDC of Large Phase IV Trials from Multiple Sites RESEARCH TRIANGLE PARK, N.C., May 12 /PRNewswire/ -- The International Collaborative Cancer Group, in collaboration with the Institute of Cancer Research Clinical Trials and Statistics Unit, is running the Intergroup Exemestane Study (IES). IES is a rand...
Max Neeman International Expands its Pharmacy Services Facility in Delhi Max Neeman International, a leading India based Contract Research Organization and subsidiary of the Max India group, expands its Pharmacy services facility in Delhi to over 4000 square feet...
Max Neeman International and AMEDON Collaborate to Increase EDC Performance Max Neeman International offers additional electronic data management system in collaboration with German software company, AMEDON GmbH for enhanced and expanded Electronic Data Capture (EDC) services....
Max Neeman International Sets Up a New Vertical for Nutraceutical Studies Research Triangle Park, NC (PR Newswire) April 26, 2010 - Max Neeman International, a leading Indian CRO, expands its list of services with the formation of an exclusive team to conduct studies on Nutraceuticals. There is an emerging trend in the Nutrace...
Top Five Pharmaceutical Company Joins with Max Neeman on Groundbreaking Diabetes, Hypertension Prevalence Study RESEARCH TRIANGLE PARK, N.C., Jan. 6 /PRNewswire/ -- One of the top global pharmaceutical companies has initiated an observational study on the prevalence of Diabetes and Hypertension called SITE (Screening India\'s Twin Epidemics) in collaboration with Ma...
Max Neeman International has set up an exclusive team for conducting Minimally Invasive Surgery Studies in collaboration with Max Healthcare. Research Triangle Park, NC (PR Newswire) February 15, 2010 – Max Neeman International, a leading Indian CRO, has formed an exclusive team of India’s finest, most experienced Physicians to conduct Minimally Invasive Surgery Studies. The team consists of t...
Max Neeman to Open Phase I/IIa Unit Max Neeman, a leading Indian CRO, announced a partnership with Max Healthcare to open a Phase I/IIa clinical trial unit at Max Super Speciality Hospital, New Delhi, India. ...
Indian CRO, Clinical Trials India